The Neurology Ionis Young Investigator Grant funds innovative early-career research on Angelman Syndrome to advance understanding and patient care, supported by Ionis Pharmaceuticals.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
FAST's New Investigator Award funds early-career researchers launching translational science projects focused on Angelman syndrome.
FAST’s New Investigator award funds early-career researchers advancing translational science and therapeutic innovation for Angelman syndrome.
The FAST Impact Award funds innovative translational research to advance therapies for Angelman syndrome from pre-clinical stages to IND application readiness.